Walker D M, Dolby A E
Int Arch Allergy Appl Immunol. 1975;49(3):303-9. doi: 10.1159/000231411.
The effect of disodium cromoglycate (DSCG) on the three following in vitro correlates of cell-mediated immunity has been studied: (1) Transformation of human peripheral blood lymphocytes after stimulation by an antigen, purified protein derivative and a mitogen, phytohaemagglutinin; (2) release of macrophage migration inhibitory factor, and (3) cytotoxic factor production, from these stimulated lymphocytes. At two non-toxic concentrations DSCG did not inhibit these three lymphocyte functions. These results suggest that DSCG's clinical effectiveness does not depend upon modulating cell-mediated immune response. The implications of these findings in relation to present concepts of the cellular action of DSCG and the intracellular control of the initiation of lymphocyte transformation are discussed.
已研究了色甘酸钠(DSCG)对以下三种细胞介导免疫的体外相关指标的影响:(1)抗原、纯化蛋白衍生物和丝裂原植物血凝素刺激后人外周血淋巴细胞的转化;(2)巨噬细胞迁移抑制因子的释放,以及(3)这些受刺激淋巴细胞产生的细胞毒性因子。在两种无毒浓度下,DSCG并未抑制这三种淋巴细胞功能。这些结果表明,DSCG的临床有效性并不取决于调节细胞介导的免疫反应。讨论了这些发现与目前关于DSCG细胞作用概念以及淋巴细胞转化起始的细胞内控制的关系。